D M Pharma Private Limited, a active private limited company, was established on 22 May 2012 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33119CH2012PTC033815. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹4.00 Cr.
It upholds a compliant status. Employing 204 professional, Its leadership includes Soraj Singh (Whole-Time Director), Varun Sood (Whole-Time Director), Neeraj Kumar (Whole-Time Director). Past directors included Jai Prakash Yadav, Ved Prakash Aggarwal, Rajesh Kumar Pandey. It holds ₹20.82 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 165, Ist Floor Sector 38-C, Chandigarh, Chandigarh, 160038.
U33119CH2012PTC033815
033815
22 May 2012
₹4.00 Cr
₹4.00 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into D M Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soraj Singh | Whole-Time Director | 18 Sep 2023 | Current |
| Varun Sood | Whole-Time Director | 21 Jan 2025 | Current |
| Neeraj Kumar | Whole-Time Director | 21 Oct 2022 | Current |
| Sunil Kumar | Whole-Time Director | 01 May 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 15 Jan 2020 | Past |
| Pramod Abcsdd | Director | 04 Sep 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 25 Mar 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 04 Jun 2022 | Past |
| Pramod Abcsdd | Director | 28 Oct 2020 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
D M Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.05% increase. The company also saw a substantial improvement in profitability, with a 34.23% increase in profit. The company's net worth Soared by an impressive increase of 33.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, D M Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹208,219,500.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2025 | Hdfc Bank Limited | ₹1.30 Cr | Open |
| 09 Jan 2025 | Hdfc Bank Limited | ₹2.13 M | Open |
| 02 Nov 2022 | Hdfc Bank Limited | ₹0.62 M | Open |
| 16 Oct 2020 | Axis Bank Limited | ₹1.45 Cr | Open |
| 17 Sep 2020 | Axis Bank Limited | ₹6.50 Cr | Open |
Explore comprehensive loan charge details -
D M Pharma has a workforce of 204 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of D M Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D M Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.30 Cr with Charge ID 101186494 was registered on 11 Nov 2025. was documented.
Progress on Varun Sood was appointed as a Whole-time director was appointed as a Whole-time director on 21 Jan 2025 & has been associated with this company since 10 months 8 days . was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 101032121 was registered on 09 Jan 2025. was completed.
A charge with Axis Bank Limited of Rs. 9.59 Cr registered on 02 Jul 2020 with Charge ID 100354937 was modified on 11 Dec 2024. was recorded as a recent event.
Progress on D M Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
D M Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The CIN of D M Pharma Private Limited is U33119CH2012PTC033815.
D M Pharma Private Limited is headquartered at Sco 165, Ist Floor Sector 38-C, Chandigarh, Chandigarh, 160038.
D M Pharma Private Limited was incorporated on 22 May 2012.
The current directors of D M Pharma Private Limited are
The primary industry of D M Pharma Private Limited is Manufacturing.
D M Pharma Private Limited is unlisted.
The authorized capital of D M Pharma Private Limited is ₹4.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of D M Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX